pf-06463922 has been researched along with Lymphoma--B-Cell* in 1 studies
1 other study(ies) available for pf-06463922 and Lymphoma--B-Cell
| Article | Year |
|---|---|
Lorlatinib Induces Rapid and Durable Response in Refractory Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma.
Topics: Anaplastic Lymphoma Kinase; Humans; Lactams; Lactams, Macrocyclic; Lymphoma, B-Cell | 2023 |